A Study of MRG002 in Treatment of Advanced HER-2 Positive Breast Cancer Patients
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer With Liver Metastases
Interventions: DRUG: MRG002
Sponsor: Shanghai Miracogen Inc.